Medivation, Inc. (NASDAQ:MDVN)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Recs

0
Player Avatar pchop123 (76.57) Submitted: 7/2/2012 9:47:31 PM : Outperform Start Price: $47.31 MDVN Score: +4.67

MDV3100

Report this Post Reply

Featured Broker Partners


Advertisement